Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis

Circulation

Volumn 123, Issue 3, 2011, Pages 299-308

  Tamburino, Corrado ^a,b   Capodanno, Davide ^a,b   Ramondo, Angelo ^c   Petronio, Anna Sonia ^d   Ettori, Federica ^e   Santoro, Gennaro ^f   Klugmann, Silvio ^g   Bedogni, Francesco ^h   Maisano, Francesco ⁱ   Marzocchi, Antonio ^j   Poli, Arnaldo ^k   Antoniucci, David ^f   Napodano, Massimo ^c   De Carlo, Marco ^d   Fiorina, Claudia ^e   Ussia, Gian Paolo ^a  

^a Ferrarotto Hospital   (Italy)

^b ETNA Foundation   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY HOSPITAL OF PISA   (Italy)

^e SPEDALI CIVILI   (Italy)

^f CAREGGI UNIVERSITY HOSPITAL   (Italy)

^g OSPEDALE NIGUARDA CA GRANDA   (Italy)

^h Sant'Ambrogio Clinical Institute   (Italy)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k Ospedale Civile   (Italy)

more..

Author keywords

aortic stenosis; aortic valve; transcatheter aortic valve implantation; valve prosthesis

Indexed keywords

AGED; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; BLEEDING; BLOOD VESSEL RUPTURE; CHRONIC KIDNEY DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE EJECTION FRACTION; HEART TAMPONADE; HUMAN; INCIDENCE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK; STROKE; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; FOLLOW-UP STUDIES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; MALE; PREDICTIVE VALUE OF TESTS; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 79251565276     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.110.946533     Document Type: Article

References (28)

1. Zajarias A, Cribier AG. Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol. 2009;53:1829-1836.
2. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcath-eter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106:3006-3008.
3. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol. 2006;47:1214-1223.
4. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol. 2007;50:69-76.
5. Webb JG, Pasupati S, Humphries K, Thompson C, Altwegg L, Moss R, Sinhal A, Carere RG, Munt B, Ricci D, Ye J, Cheung A, Lichtenstein SV. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation. 2007;116:755-763.
6. Marcheix B, Lamarche Y, Berry C, Asgar A, Laborde JC, Basmadjian A, Ducharme A, Denault A, Bonan R, Cartier R. Surgical aspects of endo-vascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis. J Thorac Cardiovasc Surg. 2007;134:1150-1156.
7. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation. 2009;119:3009-3016.
8. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv. 2008;1:167-175.
9. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following trans-catheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention. 2008;4:242-249.
10. Rodès-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianous J, Martucci G, DeVarennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, DeLarochellièere R, Teoh L, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol. 2010;55:1080-1090.
11. Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J; German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J. 2010. Sept 23. [Epub ahead of print].
12. Akins CW, Miller DC, Turina MI, Kouchoukos NT, Blackstone EH, Grunkemeier GL, Takkenberg JJ, David TE, Butchart EG, Adams DH, Shahian DM, Hagl S, Mayer JE, Lytle BW. Guidelines for reporting mortality and morbidity after cardiac valve interventions. J Thorac Cardiovasc Surg. 2008;135:732-738. (Pubitemid 351417944)
13. Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, Khandheria BK, Levine RA, Marx GR, Miller FA Jr, Nakatani S, Quiñones MA, Rakowski H, Rodriguez LL, Swaminathan M, Waggoner AD, Weissman NJ, Zabalgoitia M. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echo-cardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echo-cardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2009;22:975-1014.
14. Ussia GP, Capodanno D, Barbanti M, Scarabelli M, Imme S, Cammalleri V, Mule M, Pistritto A, Aruta P, Tamburino C. Balloon aortic valvulo-plasty for severe aortic stenosis as a bridge to high-risk transcatheter aortic valve implantation. J Invasive Cardiol. 2010;22:161-166.
15. Tamburino C, Capodanno D, Mulè M, Scarabelli M, Cammalleri V, Barbanti M, Calafiore A, Ussia G. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol. 2009;21:93-98.
16. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Michev I, Lange R, Anderson WN, Wendler O. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: A European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122: 62-69.
17. Brown ML, Schaff HV, Sarano ME, Li Z, Sundt TM, Dearani JA, Mullany CJ, Orszulak TA. Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement? J Thorac Cardiovasc Surg. 2008;136:566-571.
18. Baan J Jr, Yong ZY, Koch KT, Henriques JP, Bouma BJ, Vis MM, Cocchieri R, Piek JJ, de Mol BA. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis. Am Heart J. 2010;159:497-503.
19. Avanzas P, Muñoz Garća AJ, Segura J, Pan M, Alonso-Briales JH, Lozano I, Moŕs C, Suárez de Lezo J, Hernández- Garća JM. Percutaneous implantation of the CoreValve self-expanding aortic valve prosthesis in patients with severe aortic stenosis: early experience in Spain. Rev Esp Cardiol. 2010;63:141-148.
20. Calvi V, Puzzangara E, Pruiti GP, Conti S, Di Grazia A, Ussia GP, Capodanno D, Tamburino C. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol. 2009; 32(Suppl 1):126-130.
21. Appelros, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke. 2003;34:122-126.
22. Lee TC, Goodman SG, Yan RT, Grondin FR, Welsh RC, Rose B, Gyenes G, Zimmerman RH, Brossoit R, Saposnik G, Graham JJ, Yan AT; Canadian Acute Coronary Syndromes I and II, Canadian Global Registry of Acute Coronary Events (GRACE/GRACE2) and the Canadian Registry of Acute Coronary Events (CANRACE) Investigators. Disparities in management patterns and outcomes of patients with non-ST-elevation acute coronary syndrome with and without a history of cere-brovascular disease. Am J Cardiol. 2010;105:1083-1089.
23. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, Van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K; ESC Committee for Practice Guidelines, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008;29:2388-2442.
24. Bagur R, Webb JG, Nietlispach F, Dumont E, De Larochellière R, Doyle D, Masson JB, Gutièrrez MJ, Clavel MA, Bertrand OF, Pibarot P, Rodès-Cabau J. Acute kidney injury following transcatheter aortic valve implantation: predictive factors, prognostic value, and comparison with surgical aortic valve replacement. Eur Heart J. 2010;31:865-874.
25. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034-2047.
26. Strauch JT, Scherner MP, Haldenwang PL, Pfister R, Kuhn EW, Mad-ershahian N, Rahmanian P, Wippermann J, Wahlers T. Minimally invasive transapical aortic valve implantation and the risk of acute kidney injury. Ann Thorac Surg. 2010;89:465-470.
27. Abdel-Wahab M, Zahn R, Sherif M, Schneider S, Gerckens U, Schuler G, Sievert H, Eggebrecht H, Senges J, Richardt G. In-hospital outcome of aortic regurgitation after TAVI: results from the prospective multicentre German TAVI registry. Eur Heart J. 2010;31(Suppl 1):160.
28. Leon MB, Smith CR, Mack M, Miller C, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Brown DL, Block PC, Guyton RA, Pichard AD, Bavaria JE, Herrmann HC, Douglas PS, Petersen JL, Akin JJ, Anderson WN, Wang D, Pocock S; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597-1607.